O6-methylguanine DNA methyltransferase status determined by promoter methylation and immunohistochemistry in gliosarcoma and their clinical implications

MLA

Chul-Kee Park, et al. “O6-Methylguanine DNA Methyltransferase Status Determined by Promoter Methylation and Immunohistochemistry in Gliosarcoma and Their Clinical Implications.” Journal of Neuro-Oncology, vol. 101, June 2010, pp. 477–86. EBSCOhost, https://doi.org/10.1007/s11060-010-0267-9.

APA

Chul-Kee Park, Mi Ok Yu, Kyung Jae Park, Sung Hye Park, Shin Hyuk Kang, Chae-Yong Kim, & Yong Gu Chung. (2010). O6-methylguanine DNA methyltransferase status determined by promoter methylation and immunohistochemistry in gliosarcoma and their clinical implications. Journal of Neuro-Oncology, 101, 477–486. https://doi.org/10.1007/s11060-010-0267-9

Chicago

Chul-Kee Park, Mi Ok Yu, Kyung Jae Park, Sung Hye Park, Shin Hyuk Kang, Chae-Yong Kim, and Yong Gu Chung. 2010. “O6-Methylguanine DNA Methyltransferase Status Determined by Promoter Methylation and Immunohistochemistry in Gliosarcoma and Their Clinical Implications.” Journal of Neuro-Oncology 101 (June): 477–86. doi:10.1007/s11060-010-0267-9.